Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Nuclear Medicine|July 25, 2017
Vertebral Myeloma Mimicking Prostatic Carcinoma Metastasis in 68Ga-PSMA PET/CTEsben Hoej Merrild, Steen Baerentzen, Kirsten Bouchelouche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 13, 2017
Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planningSusanne Rylander, Simon Buus, Erik M Pedersen, et al.
Brachytherapy|July 13, 2015
The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapySusanne Rylander, Simon Buus, Lise Bentzen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancerSimon Buus, Cai Grau, Ole Lajord Munk, et al.
Brachytherapy|September 23, 2017
Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRISimon Buus, Maria Lizondo, Steffen Hokland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2006
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PETSimon Buus, Cai Grau, Ole Lajord Munk, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2010
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrodeLise Saksø Mortensen, Simon Buus, Marianne Nordsmark, et al.
Prostate Cancer and Prostatic Diseases|June 5, 2021
Androgen deprivation therapy and cognitive decline-associations with brain connectomes, endocrine status, and risk genotypesCecilie R Buskbjerg, Ali Amidi, Simon Buus, et al.
Brachytherapy|May 26, 2016
Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancerSimon Buus, Susanne Rylander, Steffen Hokland, et al.
Cancer|December 22, 2020
Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in patients with newly diagnosed prostate cancer referred to androgen-deprivation therapyCecilie R Buskbjerg, Robert Zachariae, Simon Buus, et al.
Pageof 2